Your browser doesn't support javascript.
loading
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.
Thomas, Anish; Vilimas, Rasa; Trindade, Christopher; Erwin-Cohen, Rebecca; Roper, Nitin; Xi, Liqiang; Krishnasamy, Venkatesh; Levy, Elliot; Mammen, Andy; Nichols, Samantha; Chen, Yuanbin; Velcheti, Vamsidhar; Yin, Faye; Szabo, Eva; Pommier, Yves; Steinberg, Seth M; Trepel, Jane B; Raffeld, Mark; Young, Howard A; Khan, Javed; Hewitt, Stephen; Lee, Jung-Min.
Afiliação
  • Thomas A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Electronic address: anish.thomas@nih.gov.
  • Vilimas R; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Trindade C; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Erwin-Cohen R; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • Roper N; Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Xi L; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Krishnasamy V; Interventional Radiology, National Institutes of Health Clinical Center, Bethesda, Maryland.
  • Levy E; Interventional Radiology, National Institutes of Health Clinical Center, Bethesda, Maryland.
  • Mammen A; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland.
  • Nichols S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Chen Y; Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan.
  • Velcheti V; Thoracic Medical Oncology, Perlmutter Cancer Center, New York University, New York, New York.
  • Yin F; Western Maryland Regional Medical Center, Schwab Family Cancer Center, Cumberland, Maryland.
  • Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Pommier Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Raffeld M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Young HA; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Hewitt S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
J Thorac Oncol ; 14(8): 1447-1457, 2019 08.
Article em En | MEDLINE | ID: mdl-31063862
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ftalazinas / Piperazinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ftalazinas / Piperazinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos